Silodosin Capsule
Product Images NDC 27241-144

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Silodosin (NDC 27241-144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Silodosin-4mg-30 (Silodosin 4mg 30)

Silodosin Capsules 4 mg oral capsule label manufactured by Ajanta Pharma USA Inc. The label indicates the package contains 30 capsules. Storage instructions include controlled room temperature storage (20°C to 25°C) with permitted excursions and protection from light and moisture. The package is child-resistant and includes lot and expiration date areas.*

FDA Label Image

Silodosin-8mg-30 (Silodosin 8mg 30)

Silodosin Capsules 8 mg oral capsules label by Ajanta Pharma USA Inc. The label indicates a package containing 30 capsules with prescription only status. It features storage instructions, dosage information, barcode, and placeholders for lot and expiration details. The product is made in India and marketed by Ajanta Pharma USA Inc.*

FDA Label Image

Silodosin-8mg-90 (Silodosin 8mg 90)

Silodosin 8 mg capsules label for oral use, containing 90 capsules. The label displays dosage instructions, storage conditions, and manufacturer details, Ajanta Pharma USA Inc., Bridgewater, NJ. The packaging emphasizes child resistance and includes an NDC number, barcode, and space for lot and expiration information.*

FDA Label Image

Figure1 (Silodosin Fig1)

A line graph showing silodosin concentration (ng/mL) in blood plasma over time (hours). Concentration rises rapidly, peaking around 3-4 hours post-dose, then gradually declines towards 24 hours. Error bars indicate variability at each time point.*

FDA Label Image

Figure2 (Silodosin Fig2)

A line graph comparing change from baseline in IPSS total score over time (days) between Silodosin capsules 8 mg and placebo. The x-axis shows days from baseline to day 84, and the y-axis shows change in IPSS score. Silodosin shows a greater reduction in IPSS score compared to placebo with statistical significance indicated.*

FDA Label Image

Figure3 (Silodosin Fig3)

Line graph showing the change from baseline in IPSS Total Score over days for Silodosin 8 mg capsules compared to placebo. The graph plots data points at baseline, 3.5, 7, 14, 28, and 84 days, indicating a greater decrease in IPSS score for Silodosin versus placebo, with significance noted at p<0.0001.*

FDA Label Image

Figure4 (Silodosin Fig4)

A line graph showing change from baseline in Qmax (mL/sec) over time in days for Silodosin Capsules 8 mg versus placebo. The graph illustrates higher changes in Qmax for Silodosin 8 mg compared to placebo throughout the study period, with statistically significant differences noted.*

FDA Label Image

Figure5 (Silodosin Fig5)

A line graph depicting change from baseline in Qmax (mL/sec) over days for Silodosin 8 mg capsules compared to placebo. The x-axis shows time points (Baseline, Day 1, 7, 14, 28, and 84/LOCF), and the y-axis displays change in Qmax. Silodosin shows consistently higher improvement than placebo, with statistical significance indicated at multiple points (p<0.05).*

FDA Label Image

Structure (Silodosin Structure)

Chemical structure of silodosin, showing its molecular framework including aromatic rings, amide groups, and functional side chains.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.